The combination of ervogastat plus clesacostat was more effective at resolving metabolic dysfunction-associated steatohepatitis (MASH) without worsening fibrosis in patients with biopsy-confirmed MASH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback